glp-1 rheumatoid arthritis Glucagon-like Peptide-1 Receptor Agonists in Arthritis: A Scoping Review of Metabolic, Anti-Inflammatory, and Cardioprotective Effects GLP-1 Receptor Agonists Reduce Mortality

BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500

Dangerous Interactions with PDE5 Inhibitors This is the single most critical safety warning

Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway

Wang Y, Li L, Yang M, Liu H, Boden G, Yang G

Lin YK, Leu YL, Yang SH, Chen HW, Wang CT, Pang JH

Neuropharmacology 24 : 4350 Tidey JW, Miczek KA